Plagued by indecision? Drug may boost confidence, help treat schizophrenia, OCD

thiswaythatway

Life is full of decisions, and sometimes itโ€™s difficult to know if youโ€™re making the right one. But a drug that blocks the rush of noradrenaline through your body can boost your confidence, and may also lead to new treatments for schizophrenia and obsessive compulsive disorder.

To investigate [the neural underpinnings of metacognition], Tobias Hauser at University College Londonย asked 40 people to take a drug that blocks dopamine or noradrenaline either before or after a placebo. Another 20 people received two doses of the placebo drug.

Eighty minutes after receiving the second drug, the subjects performed a task [that involved making a decision].

The drug that reduced noradrenaline boosted metacognitive insight โ€“ it made volunteers more aware of their own performance, without affecting the accuracy of their decisions.

โ€œThis study is…the first to show that metacognition can be selectively enhanced by drugs in the absence of differences in task performance,โ€ says Steve Fleming, at University College London…

Blocking noradrenaline seems to allow people to better assess their confidence in an action. The drug, called propranolol, is currently used to treat high blood pressure, but it may also prove useful for treating psychiatric symptoms like some of those seen in OCD and schizophrenia.

[Read the full study here]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:ย Drug that boosts confidence in your own actions may help OCD

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT-Image-May-13-2026-11_56_08-AM
After slashing global health aid by $19 Billion, Trump moves to tap $2.1 billion moreโ€”to cover shutdown costs
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Foodโ€”health harming industries or life-saving innovators?
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.โ€™s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
images
The never-ending GMO debate: Pros and cons
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.